Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (391-400 of 770) with videos related to

Pageof 77
Sort By:
Cardiovascular Therapeutics|February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trialsHenry Krum, John J V McMurray, Edward Horton, et al.
European Heart Journal|February 5, 2010
Towards a new order in cardiovascular medicine: re-engineering through global collaborationRobert M Califf, Paul W Armstrong, Christopher B Granger, et al.
Circulation|June 10, 2009
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarctionMark Y Chan, Jie L Sun, L Kristin Newby, et al.
European Heart Journal. Digital Health|January 30, 2023
Mapping and quantification of the twitter footprint of cardiologistsAnkur Kalra, Ashish Kumar, Amy S Nowacki, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
American Heart Journal|March 29, 2008
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of careMonica R Shah, David J Whellan, Eric D Peterson, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
American Heart Journal|July 29, 2014
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study populationMichael A Blazing, Robert P Giugliano, Christopher P Cannon, et al.
Circulation. Cardiovascular Genetics|November 26, 2014
Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular eventsSharif A Halim, Megan L Neely, Karen S Pieper, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Pageof 77

Showing results (391-400 of 770) with videos related to

Sort By:
Pageof 77
Cardiovascular Therapeutics|February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trialsHenry Krum, John J V McMurray, Edward Horton, et al.
European Heart Journal|February 5, 2010
Towards a new order in cardiovascular medicine: re-engineering through global collaborationRobert M Califf, Paul W Armstrong, Christopher B Granger, et al.
Circulation|June 10, 2009
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarctionMark Y Chan, Jie L Sun, L Kristin Newby, et al.
European Heart Journal. Digital Health|January 30, 2023
Mapping and quantification of the twitter footprint of cardiologistsAnkur Kalra, Ashish Kumar, Amy S Nowacki, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
American Heart Journal|March 29, 2008
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of careMonica R Shah, David J Whellan, Eric D Peterson, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
American Heart Journal|July 29, 2014
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study populationMichael A Blazing, Robert P Giugliano, Christopher P Cannon, et al.
Circulation. Cardiovascular Genetics|November 26, 2014
Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular eventsSharif A Halim, Megan L Neely, Karen S Pieper, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Pageof 77